NEW YORK (Reuters Health) – Patients with type 2 diabetes without retinopathy can be safely screened for sight-threatening vision problems every 3 years instead of every 1 or…
NEW YORK (Reuters Health) – Very small breast tumors that generate extensive lymph node involvement may be more biologically aggressive than larger tumors with the same degree of…
NEW YORK (Reuters Health) – For patients with idiopathic sudden sensorineural hearing loss, intratympanic injection of corticosteroids is no better or worse than oral corticosteroid therapy, but is…
NEW YORK (Reuters Health) – Results of a meta-analysis confirm that the oral tyrosine kinase inhibitor gefitinib is effective as first-line therapy in patients with advanced non-small-cell lung…
NEW YORK (Reuters Health) – Pediatric patients undergoing minor but painful procedures experience significantly less pain when given inhaled nitrous oxide, according to the results of a randomized…
NEW YORK (Reuters Health) – The combination of niacin and fenofibrate, along with diet and exercise, markedly improves the lipid profile of HIV patients on antiretroviral therapy (ART),…
NEW YORK (Reuters Health) – In patients with both carotid and coronary stenosis, a percutaneous approach to treating both sites — simultaneously or within a close period —…
NEW YORK (Reuters Health) – It’s possible for pediatricians to detect autism spectrum disorders (ASD) and other developmental delays at the 1-year well-baby check-up using a simple screening…
NEW YORK (Reuters Health) – Steroid nasal spray does not have a beneficial effect on the tympanometric signs and symptoms of eustachian tube dysfunction in school-aged children and…
NEW YORK (Reuters Health) – Pooled data from four TAXUS trials show that at 5 years, target lesion revascularization rates are consistently lower when the paclitaxel-eluting stent (PES)…
